Address: Irish BioIndustry Association, Confederation House, 84-86 Lower Baggot Street, Dublin 2,Ireland
Tel: (01) 605 1500
Web: http://www.ibec.ie/
The Irish BioIndustry Association (IBIA) is the leading representative body for the Biotechnology Industry in Ireland, has over 50 member companies and is affiliated to IBEC. The main aim of IBIA is to promote, support and encourage the further development of the multinational and indigenous biotech sector in Ireland. IBIA achieves this by building and maintaining excellent relations and a positive profile with Government, public agencies, other representative organisations, international bodies and patient groups.
Mission Statement
To enhance the environment in Ireland for the development of a successful multinational and indigenous sector in biotechnology sector
Strategic ObjectivesTo ensure a regulatory regime exists which allows biotechnology companies to prosper and grow
To communicate effectively to all stakeholders the benefits of biotechnology to society.
To actively promote research and development in biotechnology and related sciences and partnerships between industry and third level.
To actively promote an educational infrastructure which will be supportive of the biotechnology sector.
To actively participate in the work of the biotechnology industry in the rest of the European Union.
To promote a business environment which will enhance the development of the biotech sector on the whole island of Ireland.
Recent announcements from Ipsen and AbbVie of multimillion Euro investments into Irish manufacturing plants underline the Celtic nation’s continuing attractiveness to pharma multinationals. While an upcoming hike in Ireland’s famously…
The latest news from Irish pharma, including a big new R&D investment for Abbott; contact lens giant Bausch & Lomb’s EUR 90 million manufacturing investment; and a new report on…
Eoin Vaughan, CEO of Mercury Engineering, and Dermot Gildea, Director of Life Sciences, highlight the key priorities of their exciting new Mercury 2021 strategy, the rationale behind their transition into…
David Adlam, Regional Manager of Ireland and South West UK, and Paul Morris, Strategic Account Manager for Life Sciences at Agility, discuss the company’s increased commitment to Ireland, their ongoing…
Jean Delaney, pharma leader and partner at PwC Ireland, discusses the evolution she has seen in the pharma market, and more broadly in Ireland, during her extensive career at PwC.…
These are exciting times for Ipsen in Ireland, with plans to expand the company’s already significant API manufacturing footprint to deal with increasing global demand for its products. “Sales from…
The UK’s decision to leave the EU in Summer 2016 sent shockwaves throughout Europe and left neighbouring countries struggling to interpret what ‘Brexit’ means for them. Ireland, as the UK’s…
Philip Hendrick, the Managing Director of Air Liquide Healthcare Ireland, a provider of home-based respiratory solutions, discusses the changes that the Irish healthcare system is going through, and how they…
Philip Martin, founder and CEO of Cora Systems in Ireland, explains why his company is ideally positioned to help the pharmaceutical industry increase efficiency and save costs through their agile,…
Brendan McAtamney, CEO of UDG Healthcare, details the company’s impressive growth in recent years, particularly in North America, across both their Sharp and Ashfield business units. He also expands on…
Grünenthal Ireland’s General Manager discusses the incredible growth of the Irish affiliate over the past twelve years, their comprehensive pain portfolio, the innovation they are bringing as pain specialists to…
Much like the Irish sport of hurling, conducting R&D in Ireland is something often overlooked – unfairly, as proponents would say. Ireland has always faced a number of intrinsic hurdles…
See our Cookie Privacy Policy Here
